XML 66 R56.htm IDEA: XBRL DOCUMENT v3.20.2
Stockholders' Equity - Restricted stock (Details) - USD ($)
$ / shares in Units, $ in Millions
1 Months Ended 3 Months Ended 6 Months Ended
Apr. 30, 2020
Mar. 31, 2020
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Equity-based compensation expense     $ 3.3 $ 0.2 $ 5.5 $ 5.4
Single Employee [Member]            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Granted, shares 20,656 300,000        
Vesting percentage 33.00% 25.00%        
Grant date fair value $ 0.3 $ 4.9        
Number of trading days 10 days          
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]            
Granted, shares 20,656 300,000        
Various Employees [Member]            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Granted, shares   341,123 78,536      
Vesting period     4 years      
Grant date fair value   $ 5.6 $ 1.3      
Equity-based compensation expense   0.3        
Compensation cost, portion to be recognized over service period   $ 5.3        
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]            
Granted, shares   341,123 78,536      
Restricted Stock            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Granted, shares         740,000  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]            
Non-vested balance at beginning of period         901,000  
Granted, shares         740,000  
Vested, shares         (20,000)  
Forfeited, shares         (20,000)  
Non-vested balance at end of period     1,601,000   1,601,000  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]            
Non-vested, grant date fair value at beginning of period         $ 5.83  
Granted, grant date fair value         16.22  
Vested, grant date fair value         14.33  
Forfeited, grant date fair value         8.11  
Non-vested, grant date fair value at end of period     $ 10.49   $ 10.49  
Tranche 1 | Single Employee [Member]            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Granted, shares   250,000        
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]            
Granted, shares   250,000        
Tranche 1 | Various Employees [Member]            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Granted, shares   15,417        
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]            
Granted, shares   15,417        
Tranche 2 | Single Employee [Member]            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Granted, shares   50,000        
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]            
Granted, shares   50,000        
Tranche 2 | Various Employees [Member]            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Vesting percentage   25.00%